Nifty
Sensex
:
:
24013.10
76802.90
-154.90 (-0.64%)
-607.08 (-0.78%)

Pharmaceuticals & Drugs - API

Rating :
62/99

BSE: 532488 | NSE: DIVISLAB

6743.00
19-Jun-2026
  • Open
  • High
  • Low
  • Previous Close
  •  6790
  •  6795
  •  6716.5
  •  6767.00
  • Volume
  • Traded Value (lacs)
  • 52 Week High
  • 52 Week Low
  •  372371
  •  2513603752.5
  •  7071.5
  •  5636.5

Stock Summary

  • Market Cap(Crs)
  • Stock P:E
  • Face Value
  • 1,78,956.35
  • 69.69
  • 2
  • Enterprise Value(Crs)
  • Dividend Yield
  • Price:Book Value
  • 1,75,542.35
  • 0.45%
  • 10.68

Shareholding Pattern

  • Promoter
  • Corporate
  • Public
  • 51.88%
  • 1.19%
  • 6.47%
  • FII
  • DII
  • Others
  • 20.29%
  • 18.25%
  • 1.92%

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 9.50
  • 6.08
  • 6.42

EBITDA CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 7.67
  • 0.74
  • 4.62

PAT CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 6.89
  • 2.00
  • 6.30

P:E (Median)

  • 8 Years
  • 5 Years
  • 3 Years
  • 53.50
  • 67.09
  • 72.81

P:BV (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • 9.14
  • 9.70
  • 9.74

EV:EBITDA (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • 35.81
  • 39.48
  • 45.63

Quarterly Results

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 26
Mar 25
Var%
Dec 25
Dec 24
Var%
Sep 25
Sep 24
Var%
Jun 25
Jun 24
Var%
Net Sales
2,831.00
2,585.00
9.52%
2,604.00
2,319.00
12.29%
2,715.00
2,338.00
16.12%
2,410.00
2,118.00
13.79%
Expenses
1,897.00
1,699.00
11.65%
1,714.00
1,576.00
8.76%
1,827.00
1,622.00
12.64%
1,681.00
1,496.00
12.37%
EBITDA
934.00
886.00
5.42%
890.00
743.00
19.78%
888.00
716.00
24.02%
729.00
622.00
17.20%
EBIDTM
32.99%
34.27%
34.18%
32.04%
32.71%
30.62%
30.25%
29.37%
Other Income
155.00
86.00
80.23%
88.00
82.00
7.32%
145.00
106.00
36.79%
119.00
79.00
50.63%
Interest
6.00
1.00
500.00%
6.00
0.00
0
8.00
1.00
700.00%
3.00
0.00
0
Depreciation
120.00
107.00
12.15%
118.00
99.00
19.19%
113.00
99.00
14.14%
112.00
97.00
15.46%
PBT
963.00
864.00
11.46%
780.00
726.00
7.44%
912.00
722.00
26.32%
733.00
604.00
21.36%
Tax
212.00
202.00
4.95%
197.00
137.00
43.80%
223.00
212.00
5.19%
188.00
174.00
8.05%
PAT
751.00
662.00
13.44%
583.00
589.00
-1.02%
689.00
510.00
35.10%
545.00
430.00
26.74%
PATM
26.53%
25.61%
22.39%
25.40%
25.38%
21.81%
22.61%
20.30%
EPS
28.34
24.98
13.45%
22.00
22.23
-1.03%
26.00
19.25
35.06%
20.57
16.23
26.74%

Annual Results

Consolidated Figures in Rs. Crores /

Standalone
Description
TTM
Mar 25
Mar 24
Mar 23
Mar 22
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Net Sales
10,560.00
9,360.00
7,845.00
7,767.00
8,959.83
6,969.40
5,394.42
4,946.26
3,891.49
4,064.34
3,776.36
Net Sales Growth
12.82%
19.31%
1.00%
-13.31%
28.56%
29.20%
9.06%
27.10%
-4.25%
7.63%
 
Cost Of Goods Sold
4,093.00
3,725.00
3,129.00
3,053.00
2,967.14
2,324.08
2,108.54
1,825.22
1,534.06
1,534.00
1,505.32
Gross Profit
6,467.00
5,635.00
4,716.00
4,714.00
5,992.69
4,645.32
3,285.88
3,121.04
2,357.43
2,530.34
2,271.04
GP Margin
61.24%
60.20%
60.11%
60.69%
66.88%
66.65%
60.91%
63.10%
60.58%
62.26%
60.14%
Total Expenditure
7,119.00
6,391.00
5,639.00
5,398.00
5,078.72
4,108.34
3,571.21
3,073.24
2,628.74
2,617.20
2,358.04
Power & Fuel Cost
-
465.00
477.00
496.00
392.33
319.15
280.73
248.78
228.73
198.80
180.34
% Of Sales
-
4.97%
6.08%
6.39%
4.38%
4.58%
5.20%
5.03%
5.88%
4.89%
4.78%
Employee Cost
-
1,243.00
1,094.00
975.00
946.16
825.76
621.05
542.27
456.06
499.90
361.19
% Of Sales
-
13.28%
13.95%
12.55%
10.56%
11.85%
11.51%
10.96%
11.72%
12.30%
9.56%
Manufacturing Exp.
-
416.00
425.00
401.00
365.92
297.84
258.91
212.96
182.67
169.15
169.42
% Of Sales
-
4.44%
5.42%
5.16%
4.08%
4.27%
4.80%
4.31%
4.69%
4.16%
4.49%
General & Admin Exp.
-
335.00
283.00
304.00
236.44
175.26
148.62
105.30
139.33
88.22
73.91
% Of Sales
-
3.58%
3.61%
3.91%
2.64%
2.51%
2.76%
2.13%
3.58%
2.17%
1.96%
Selling & Distn. Exp.
-
136.00
90.00
114.00
127.01
124.03
85.36
73.08
64.02
67.48
56.04
% Of Sales
-
1.45%
1.15%
1.47%
1.42%
1.78%
1.58%
1.48%
1.65%
1.66%
1.48%
Miscellaneous Exp.
-
71.00
141.00
55.00
43.72
42.22
68.00
65.63
23.87
59.65
56.04
% Of Sales
-
0.76%
1.80%
0.71%
0.49%
0.61%
1.26%
1.33%
0.61%
1.47%
0.31%
EBITDA
3,441.00
2,969.00
2,206.00
2,369.00
3,881.11
2,861.06
1,823.21
1,873.02
1,262.75
1,447.14
1,418.32
EBITDA Margin
32.59%
31.72%
28.12%
30.50%
43.32%
41.05%
33.80%
37.87%
32.45%
35.61%
37.56%
Other Income
507.00
352.00
339.00
345.00
115.90
62.67
189.63
155.63
113.44
74.89
97.44
Interest
23.00
3.00
4.00
2.00
2.00
2.10
7.14
4.68
2.37
3.36
4.74
Depreciation
463.00
402.00
378.00
343.00
311.51
255.59
186.24
168.90
142.49
123.33
118.18
PBT
3,388.00
2,916.00
2,163.00
2,369.00
3,683.50
2,666.04
1,819.46
1,855.07
1,231.33
1,395.34
1,392.84
Tax
820.00
725.00
563.00
545.00
723.05
681.75
442.92
502.33
354.32
334.92
267.06
Tax Rate
24.20%
24.86%
26.03%
23.01%
19.63%
25.57%
24.34%
27.08%
28.78%
24.00%
19.17%
PAT
2,568.00
2,191.00
1,600.00
1,824.00
2,960.45
1,984.29
1,376.54
1,352.74
877.01
1,060.42
1,125.78
PAT before Minority Interest
2,568.00
2,191.00
1,600.00
1,824.00
2,960.45
1,984.29
1,376.54
1,352.74
877.01
1,060.42
1,125.78
Minority Interest
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
PAT Margin
24.32%
23.41%
20.40%
23.48%
33.04%
28.47%
25.52%
27.35%
22.54%
26.09%
29.81%
PAT Growth
17.21%
36.94%
-12.28%
-38.39%
49.19%
44.15%
1.76%
54.24%
-17.30%
-5.81%
 
EPS
96.72
82.52
60.26
68.70
111.50
74.74
51.85
50.95
33.03
39.94
42.40

Results Balance Sheet

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 25
Mar 24
Mar 23
Mar 22
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Shareholder's Funds
14,969.00
13,571.00
12,767.00
11,728.18
9,294.61
7,309.92
6,957.15
5,924.80
5,357.39
4,293.31
Share Capital
53.00
53.00
53.00
53.09
53.09
53.09
53.09
53.09
53.09
53.09
Total Reserves
14,916.00
13,518.00
12,714.00
11,675.09
9,241.52
7,256.83
6,904.06
5,871.71
5,304.30
4,240.21
Non-Current Liabilities
500.00
611.00
557.00
436.51
363.94
294.57
991.38
1,768.91
1,411.75
85.17
Secured Loans
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Unsecured Loans
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.47
Long Term Provisions
0.00
37.00
31.00
26.71
25.42
20.52
772.54
1,577.26
1,288.92
11.57
Current Liabilities
2,248.00
1,755.00
1,539.00
2,454.44
1,728.35
1,820.53
846.75
653.42
659.45
519.50
Trade Payables
910.00
824.00
762.00
795.70
763.20
590.72
492.26
411.21
445.80
232.69
Other Current Liabilities
486.00
404.00
332.00
394.02
340.42
290.09
243.59
175.46
176.63
240.58
Short Term Borrowings
2.00
0.00
0.00
0.00
0.35
33.63
105.60
63.11
35.74
41.42
Short Term Provisions
850.00
527.00
445.00
1,264.72
624.38
906.09
5.30
3.64
1.28
4.81
Total Liabilities
17,717.00
15,937.00
14,863.00
14,619.13
11,386.90
9,425.02
8,795.28
8,347.13
7,428.59
4,897.98
Net Block
5,442.00
4,739.00
4,722.00
4,325.05
3,703.87
2,781.85
2,087.77
1,996.19
1,559.19
1,438.77
Gross Block
7,868.00
6,760.00
6,365.00
5,624.27
4,691.86
3,514.25
2,633.93
2,373.45
1,793.95
2,196.08
Accumulated Depreciation
2,426.00
2,021.00
1,643.00
1,299.22
987.99
732.40
546.16
377.26
234.76
757.32
Non Current Assets
6,840.00
5,785.00
5,113.00
5,008.74
4,596.30
3,851.49
4,145.23
3,812.01
3,418.08
1,870.93
Capital Work in Progress
1,022.00
778.00
212.00
469.93
710.62
919.69
491.91
119.76
443.57
263.91
Non Current Investment
65.00
82.00
77.00
72.01
0.01
0.01
547.26
0.01
0.01
0.01
Long Term Loans & Adv.
301.00
176.00
97.00
133.70
172.59
144.50
1,012.93
1,688.23
1,406.48
162.44
Other Non Current Assets
10.00
10.00
5.00
8.05
9.21
5.44
5.36
7.82
8.83
5.80
Current Assets
10,877.00
10,152.00
9,750.00
9,610.39
6,790.60
5,573.53
4,650.05
4,535.12
4,010.51
3,027.04
Current Investments
0.00
0.00
0.00
0.00
0.00
971.35
1,398.34
1,889.28
1,630.72
802.85
Inventories
3,236.00
3,184.00
3,000.00
2,828.62
2,145.23
1,863.86
1,772.34
1,350.67
1,319.91
1,207.83
Sundry Debtors
2,731.00
2,156.00
1,793.00
2,423.88
1,676.52
1,413.35
1,163.37
1,014.36
900.92
880.92
Cash & Bank
3,715.00
3,980.00
4,214.00
2,818.88
2,156.03
122.63
115.26
112.46
78.70
73.43
Other Current Assets
1,195.00
38.00
28.00
29.69
812.82
1,202.34
200.74
168.35
80.26
62.01
Short Term Loans & Adv.
1,156.00
794.00
715.00
1,509.32
760.87
1,150.18
188.75
148.40
59.59
42.88
Net Current Assets
8,629.00
8,397.00
8,211.00
7,155.95
5,062.25
3,753.00
3,803.30
3,881.70
3,351.06
2,507.54
Total Assets
17,717.00
15,937.00
14,863.00
14,619.13
11,386.90
9,425.02
8,795.28
8,347.13
7,428.59
4,897.97

Cash Flow

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 25
Mar 24
Mar 23
Mar 22
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Cash From Operating Activity
1,653.00
1,261.00
2,459.00
1,911.80
1,946.93
1,215.94
954.30
775.86
1,150.37
1,037.86
PBT
2,916.00
2,163.00
2,369.00
3,683.50
2,666.04
1,819.46
1,855.07
1,231.33
1,395.34
1,392.84
Adjustment
115.00
81.00
144.00
239.73
189.29
60.01
83.51
32.19
93.87
60.94
Changes in Working Capital
-554.00
-607.00
419.00
-1,370.45
-264.08
-218.30
-499.84
-219.11
-37.14
-155.03
Cash after chg. in Working capital
2,477.00
1,637.00
2,932.00
2,552.78
2,591.25
1,661.17
1,438.74
1,044.41
1,452.07
1,298.75
Interest Paid
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Tax Paid
-824.00
-376.00
-473.00
-640.98
-644.32
-445.23
-484.44
-268.55
-301.70
-260.89
Other Direct Exp. Paid
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Extra & Other Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Cash From Investing Activity
-804.00
-269.00
-2,707.00
-2,194.92
75.13
-83.47
-685.40
-478.30
-1,139.60
-406.41
Net Fixed Assets
-1,351.00
-960.00
-482.38
-691.54
-968.33
-1,302.55
-632.52
-255.54
222.19
-288.75
Net Investments
17.00
-5.00
-4.63
-72.00
971.35
974.24
-56.30
-257.57
-826.05
-77.22
Others
530.00
696.00
-2,219.99
-1,431.38
72.11
244.84
3.42
34.81
-535.74
-40.44
Cash from Financing Activity
-799.00
-799.00
-797.00
-532.44
-34.89
-1,091.42
-245.94
-314.16
2.38
-631.12
Net Cash Inflow / Outflow
50.00
193.00
-1,045.00
-815.56
1,987.17
41.05
22.96
-16.60
13.15
0.33
Opening Cash & Equivalents
363.00
170.00
1,215.00
2,030.32
43.15
2.10
-20.86
-4.26
-17.41
17.62
Closing Cash & Equivalent
413.00
363.00
170.00
1,214.76
2,030.32
43.15
2.10
-20.86
-4.26
17.95

Financial Ratios

Consolidated /

Standalone
Description
Mar 25
Mar 24
Mar 23
Mar 22
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Book Value (Rs.)
564.87
512.11
481.77
441.82
350.15
275.38
262.09
223.20
201.82
161.73
ROA
13.02%
10.39%
12.37%
22.77%
19.07%
15.11%
15.78%
11.12%
17.21%
22.49%
ROE
15.35%
12.15%
14.89%
28.16%
23.90%
19.30%
21.00%
15.55%
21.98%
28.91%
ROCE
20.45%
16.46%
19.36%
35.06%
32.07%
25.36%
28.50%
21.68%
28.75%
35.57%
Fixed Asset Turnover
1.29
1.20
1.30
1.74
1.70
1.77
1.98
1.88
2.06
1.83
Receivable days
94.81
91.33
98.42
83.26
80.66
86.18
80.35
89.33
79.19
77.83
Inventory Days
124.55
143.02
136.04
100.99
104.66
121.62
115.23
124.56
112.34
113.70
Payable days
84.95
92.50
93.12
95.88
106.32
93.73
52.21
60.15
47.14
35.06
Cash Conversion Cycle
134.41
141.85
141.35
88.36
79.00
114.07
143.37
153.75
144.39
156.47
Total Debt/Equity
0.00
0.00
0.00
0.00
0.00
0.00
0.02
0.01
0.01
0.01
Interest Cover
973.00
541.75
1185.50
1842.75
1270.54
255.83
397.38
520.55
416.28
294.75

News Update:


  • Divi's Laboratories’ consolidated net profit rises 13% in Q4
    25th May 2026, 12:58 PM

    The total consolidated income of the company has increased by 11.79% at Rs 2,986.00 crore for Q4FY26

    Read More
  • Divi's Lab - Quarterly Results
    24th May 2026, 00:00 AM

    Read More

Source: www.accordfintech.com | DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.